CRIS Current Research Information System

CROCI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.641
AS - Asia 1.909
EU - Europa 1.528
AF - Africa 150
Continente sconosciuto - Info sul continente non disponibili 119
SA - Sud America 88
OC - Oceania 3
Totale 6.438
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.593
VN - Vietnam 708
SG - Singapore 445
CN - Cina 430
GB - Regno Unito 394
DE - Germania 199
IT - Italia 197
SE - Svezia 164
HK - Hong Kong 115
UA - Ucraina 95
RU - Federazione Russa 91
FR - Francia 90
IN - India 70
CH - Svizzera 67
BR - Brasile 58
IE - Irlanda 53
CI - Costa d'Avorio 47
CA - Canada 39
TG - Togo 39
JP - Giappone 38
ZA - Sudafrica 37
NL - Olanda 30
EE - Estonia 26
BG - Bulgaria 25
FI - Finlandia 24
BE - Belgio 18
BD - Bangladesh 14
RO - Romania 14
KR - Corea 13
PH - Filippine 13
AR - Argentina 10
LT - Lituania 10
PL - Polonia 9
TH - Thailandia 9
ID - Indonesia 8
NG - Nigeria 8
SC - Seychelles 8
TR - Turchia 8
CL - Cile 7
TW - Taiwan 6
CO - Colombia 5
ES - Italia 5
IR - Iran 5
JO - Giordania 5
EC - Ecuador 4
GR - Grecia 4
PK - Pakistan 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
EG - Egitto 3
IQ - Iraq 3
MX - Messico 3
PE - Perù 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
CZ - Repubblica Ceca 2
HR - Croazia 2
JM - Giamaica 2
KH - Cambogia 2
LV - Lettonia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GH - Ghana 1
KE - Kenya 1
KG - Kirghizistan 1
MA - Marocco 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZM - Zambia 1
Totale 6.321
Salva come PNG Salva come JPEG
Città #
Southend 318
Chandler 317
Singapore 303
Ashburn 288
Fairfield 268
Ho Chi Minh City 164
Hanoi 138
Woodbridge 127
Houston 124
Seattle 124
Wilmington 123
Hong Kong 108
Ann Arbor 106
Dong Ket 87
Cambridge 85
San Jose 81
Princeton 75
Santa Clara 72
Jacksonville 60
Beijing 58
Bern 58
Dublin 52
Abidjan 47
Boardman 46
Hefei 46
Lomé 39
Tokyo 32
Westminster 32
Council Bluffs 31
Nanjing 31
Bologna 29
Lauterbourg 29
Padova 29
New York 27
Dallas 26
Haiphong 25
Sofia 25
Bremen 24
Los Angeles 24
Milan 22
Jinan 21
Berlin 20
Helsinki 20
Brussels 18
Redwood City 18
Da Nang 17
Guangzhou 17
Shenyang 17
Ottawa 16
Buffalo 15
Falkenstein 15
Saint Petersburg 15
Phoenix 13
Turin 13
Changsha 12
Hebei 11
London 11
Nanchang 11
San Diego 11
Seoul 11
Frankfurt am Main 10
Hải Dương 10
Redondo Beach 10
Toronto 10
Mülheim 9
Tianjin 9
Zhengzhou 9
Atlanta 8
Jiaxing 8
Johannesburg 8
Moscow 8
São Paulo 8
Amsterdam 7
Bengaluru 7
Dearborn 7
Jakarta 7
Kuban 7
Mahé 7
Abeokuta 6
Can Tho 6
Des Moines 6
Ha Long 6
Montreal 6
Thái Nguyên 6
Warsaw 6
Yubileyny 6
Amman 5
Bulle 5
Bühl 5
Nha Trang 5
Ningbo 5
Quận Ba 5
Quận Bình Thạnh 5
Redmond 5
Taizhou 5
Washington 5
Barnet 4
Biên Hòa 4
Bắc Ninh 4
Bến Tre 4
Totale 4.265
Salva come PNG Salva come JPEG
Nome #
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER-2. 386
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome 268
Preclinical therapy of disseminated HER-2+ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus. 259
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R 248
Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor 231
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells. 219
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy 216
Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity. 211
Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role. 203
HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines 201
In silico modeling and in vivo efficacy of cancer preventive vaccinations 200
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis 189
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. 188
Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice. 188
High metastatic efficiency of human sarcoma cells in Rag2/gamma c double knockout mice provides a powerful test system for antimetastatic targeted therapy 188
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. 187
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis 187
Antimetastatic activity of a preventive cancer vaccine. 187
Human responses against HER-2-positive cancer cells in human immune system-engrafted mice. 186
Isolation and in vitro differentiation of human Mesenchymal Stem Cells from new alternative sources: fetal membranes and placenta 185
Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4. 179
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells 178
Translational immunomics of cancer prevention. 168
Immunological prevention of a multigene cancer syndrome 166
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis. 162
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis. 162
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, BRCA, PTEN, and Other Genes 156
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent 150
Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells 150
Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system 149
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12 engineered allogeneic cell vaccine 147
Toward the definition of immunosuppressive regimens with antitumor activity. 126
Expression of T cell receptor alpha gene (TCRA) in human rhabdomyosarcoma and other musculo-skeletal sarcomas. 123
null 95
Totale 6.438
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.392
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022633 0 17 55 24 54 27 18 48 26 57 178 129
2022/2023981 117 146 61 146 54 71 21 46 128 38 68 85
2023/2024209 9 41 7 26 17 48 12 18 5 11 6 9
2024/2025706 55 85 56 33 126 53 39 26 6 42 33 152
2025/20261.785 305 142 141 124 192 87 132 32 389 153 52 36
2026/202745 37 8 0 0 0 0 0 0 0 0 0 0
Totale 6.438